X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1146) 1146
index medicus (817) 817
vasculitis (671) 671
female (667) 667
male (643) 643
middle aged (565) 565
wegeners-granulomatosis (533) 533
adult (507) 507
rheumatology (506) 506
aged (440) 440
microscopic polyangiitis (425) 425
wegener's granulomatosis (297) 297
immunosuppressive agents - therapeutic use (271) 271
anca-associated vasculitis (265) 265
cyclophosphamide (265) 265
systemic vasculitis (265) 265
granulomatosis with polyangiitis (245) 245
granulomatosis with polyangiitis - drug therapy (245) 245
churg-strauss-syndrome (244) 244
antineutrophil cytoplasmic antibodies (243) 243
treatment outcome (243) 243
granulomatosis (239) 239
retrospective studies (238) 238
granulomatosis with polyangiitis - diagnosis (230) 230
granulomatosis with polyangiitis - complications (228) 228
mortality (220) 220
prognosis (204) 204
rituximab (201) 201
medicine & public health (195) 195
disease (194) 194
anca (193) 193
antibody-associated vasculitis (180) 180
diagnosis (176) 176
urology & nephrology (173) 173
adolescent (172) 172
polyarteritis-nodosa (170) 170
cyclophosphamide - therapeutic use (168) 168
therapy (168) 168
risk factors (160) 160
recurrence (158) 158
care and treatment (155) 155
classification (154) 154
randomized-trial (153) 153
antibodies, antineutrophil cytoplasmic - blood (146) 146
term-follow-up (144) 144
aged, 80 and over (142) 142
glomerulonephritis (139) 139
patients (136) 136
autoantibodies (131) 131
immunology (130) 130
follow-up studies (125) 125
granulomatosis with polyangiitis - mortality (125) 125
medicine, general & internal (122) 122
antibodies, antineutrophil cytoplasmic - immunology (121) 121
remission induction (121) 121
abridged index medicus (113) 113
biopsy (113) 113
granulomatosis with polyangiitis - pathology (112) 112
antibodies (109) 109
granulomatosis with polyangiitis - immunology (109) 109
eosinophilic granulomatosis with polyangiitis (106) 106
churg-strauss syndrome (104) 104
diagnosis, differential (104) 104
epidemiology (104) 104
drug therapy, combination (103) 103
young adult (103) 103
glucocorticoids - therapeutic use (102) 102
remission (102) 102
granulomatosis with polyangiitis - therapy (100) 100
vasculitis - immunology (99) 99
anti-neutrophil cytoplasmic antibody-associated vasculitis - drug therapy (96) 96
child (95) 95
severity of illness index (94) 94
health aspects (88) 88
research (88) 88
survival (87) 87
survival rate (86) 86
rheumatology 1990 criteria (82) 82
vasculitis - drug therapy (81) 81
small-vessel vasculitis (80) 80
vasculitis - diagnosis (80) 80
rheumatoid-arthritis (79) 79
analysis (77) 77
anti-neutrophil cytoplasmic antibody-associated vasculitis - immunology (77) 77
internal medicine (77) 77
systemic-lupus-erythematosus (77) 77
relapse (76) 76
corticosteroids (75) 75
wegener granulomatosis (75) 75
anti-neutrophil cytoplasmic antibody-associated vasculitis - diagnosis (73) 73
time factors (72) 72
anti-neutrophil cytoplasmic antibody-associated vasculitis - complications (71) 71
arthritis (71) 71
neutrophils (71) 71
medical research (70) 70
tomography, x-ray computed (70) 70
inflammation (69) 69
renal vasculitis (69) 69
antineutrophil cytoplasmic autoantibodies (67) 67
cohort studies (66) 66
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1451) 1451
German (26) 26
French (19) 19
Spanish (12) 12
Russian (4) 4
Polish (3) 3
Norwegian (2) 2
Danish (1) 1
Japanese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Arthritis & rheumatology (Hoboken, N.J.), ISSN 2326-5191, 2016, Volume 68, Issue 3, pp. 690 - 701
Journal Article
American Journal of Kidney Diseases, ISSN 0272-6386, 2015, Volume 66, Issue 4, pp. 613 - 620
Journal Article
Arthritis care & research (2010), ISSN 2151-464X, 2018, Volume 70, Issue 10, pp. 1495 - 1500
Objective To examine temporal trends in mortality rates in a large nationwide cohort of patients with end... 
IMMUNOSUPPRESSIVE THERAPY | ANTIBODY-ASSOCIATED VASCULITIS | OUTCOMES | RHEUMATOLOGY | TRENDS | DIALYSIS | Granulomatosis | Death | Trends | Kidney diseases | Medicare | Mortality
Journal Article
Journal Article
Rheumatology, ISSN 1462-0324, 04/2018, Volume 57, Issue suppl_3
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2017, Volume 12, Issue 10, pp. e0185880 - e0185880
.... We enrolled patients with granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA) and eosinophilic granulomatosis with polyangiitis... 
WEGENERS-GRANULOMATOSIS | CHURG-STRAUSS-SYNDROME | ANTIBODY-ASSOCIATED VASCULITIS | EOSINOPHILIC GRANULOMATOSIS | RENAL VASCULITIS | RITUXIMAB | MULTIDISCIPLINARY SCIENCES | AZATHIOPRINE | CLASSIFICATION | POOR-PROGNOSIS FACTORS | RHEUMATOLOGY 1990 CRITERIA | Recurrence | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Methotrexate - therapeutic use | Microscopic Polyangiitis - complications | Cyclophosphamide - therapeutic use | Microscopic Polyangiitis - mortality | Patient Selection | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - mortality | Churg-Strauss Syndrome - drug therapy | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - complications | Granulomatosis with Polyangiitis - immunology | Patient Safety | Adult | Female | Microscopic Polyangiitis - immunology | Peripheral Nervous System Diseases - complications | Peripheral Nervous System Diseases - immunology | Proteinuria - mortality | Peripheral Nervous System Diseases - mortality | Granulomatosis with Polyangiitis - mortality | Proteinuria - immunology | Treatment Outcome | Random Allocation | Remission Induction | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy | Churg-Strauss Syndrome - complications | Proteinuria - drug therapy | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - immunology | Churg-Strauss Syndrome - mortality | Adolescent | Survival Analysis | Microscopic Polyangiitis - drug therapy | Granulomatosis with Polyangiitis - drug therapy | Aged | Churg-Strauss Syndrome - immunology | Proteinuria - complications | Peripheral Nervous System Diseases - drug therapy | Antibodies, Antineutrophil Cytoplasmic - blood | Granulomatosis with Polyangiitis - complications | Complications and side effects | Cyclophosphamide | Vasculitis | Dosage and administration | Genetic aspects | Research | Methotrexate | Drug therapy | Nephrology | Transplants & implants | Hemodialysis | Toxicity | Granulomatosis | Arthritis | Peripheral neuropathy | Randomization | Antineutrophil cytoplasmic antibodies | Remission | Drug dosages | Kidneys | Internal medicine | Epidermal growth factor receptors | Leukocytes (eosinophilic) | Rheumatology | Maintenance | Patients | Medicine | Hospitals | Medical prognosis | Proteinuria | Kidney transplantation | Index Medicus
Journal Article
Arthritis care & research (2010), ISSN 2151-4658, 2018, Volume 71, Issue 1, pp. 155 - 163
Journal Article
Journal Article
Journal Article
Annals of the rheumatic diseases, ISSN 0003-4967, 06/2016, Volume 75, Issue 6, pp. 1166 - 1169
Journal Article
International journal of cardiology, ISSN 0167-5273, 2015, Volume 199, pp. 170 - 179
...) population of eosinophilic granulomatosis with polyangiitis (EGPA) and granulomatosis with polyangiitis (GPA) patients... 
Cardiovascular | Granulomatosis with polyangiitis | Cardiovascular disease | Prognosis | Systemic vasculitis | WEGENERS-GRANULOMATOSIS | CHURG-STRAUSS-SYNDROME | CARDIAC & CARDIOVASCULAR SYSTEMS | ANTIBODY-ASSOCIATED VASCULITIS | IDIOPATHIC DILATED CARDIOMYOPATHY | INFLAMMATORY DISEASES | CARDIOVASCULAR MAGNETIC-RESONANCE | GENERAL-POPULATION | VENTRICULAR DIASTOLIC DYSFUNCTION | TERM-FOLLOW-UP | ENDOMYOCARDIAL BIOPSY | Predictive Value of Tests | Prevalence | Prospective Studies | Humans | Middle Aged | Male | Churg-Strauss Syndrome - epidemiology | Churg-Strauss Syndrome - drug therapy | Cardiovascular Diseases - complications | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - complications | Granulomatosis with Polyangiitis - immunology | Aged, 80 and over | Cardiovascular Diseases - mortality | Electrocardiography | Female | Cardiac Imaging Techniques - methods | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - epidemiology | Echocardiography | Risk Factors | Granulomatosis with Polyangiitis - epidemiology | Myocardium - pathology | Patient Outcome Assessment | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy | Coronary Angiography | Magnetic Resonance Imaging | Algorithms | Churg-Strauss Syndrome - complications | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - immunology | Biopsy | Granulomatosis with Polyangiitis - drug therapy | Aged | Cohort Studies | Granulomatosis with Polyangiitis - complications | Vasculitis | Prevalence studies (Epidemiology)
Journal Article